Table 4.
Total | Normal weight | Overweight | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Age | 1.02 (0.98-1.06) | 0.313 | 1.02 (0.95-1.10) | 0.606 | 1.00 (0.96-1.05) | 0.348 |
Male | 2.18 (0.90-5.29) | 0.084 | 3.11 (0.66-14.66) | 0.152 | 1.54 (0.52-4.53) | 0.725 |
Diabetes | 2.68 (1.35-5.35) | 0.005 | 4.48 (1.26-15.87) | 0.020 | 2.79 (1.18-6.61) | 0.019 |
SBP | 1.00 (0.99-1.02) | 0.803 | 0.99 (0.97-1.02) | 0.617 | 1.00 (0.98-1.02) | 0.714 |
DBP | 1.00 (0.97-1.03) | 0.831 | 0.97 (0.92-1.02) | 0.270 | 1.00 (0.97-1.04) | 0.900 |
TG | 0.88 (0.61-1.27) | 0.494 | 0.61 (0.17-2.24) | 0.456 | 0.86 (0.58-1.29) | 0.466 |
HbA1c | 0.99 (0.75-1.30) | 0.919 | 0.62 (0.39-1.74) | 0.615 | 0.98 (0.72-1.32) | 0.877 |
caIMR≥25 | 3.19 (1.52-6.71) | 0.002 | 2.87 (0.81-10.19) | 0.103 | 3.16 (1.24-8.01) | 0.016 |
Univariate analysis enrolled factors with a P-value< 0.05 in the baseline. caIMR, coronary angiography−derived index of microcirculatory resistance; SBP, systolic blood pressure; DBP,diastolic blood pressure; TG, triglycerides; HbA1c, glycated hemoglobin; HR, hazard ratio; CI, confidence interval.